TREATMENT WITH STREPTOCOCCAL PREPARATION (OK-432) SUPPRESSES ANTI-ISLET AUTOIMMUNITY AND PREVENTS DIABETES IN BB RATS

被引：38

作者：

SATOH, J ^{[1
]}

SHINTANI, S ^{[1
]}

OYA, K ^{[1
]}

TANAKA, SI ^{[1
]}

NOBUNAGA, T ^{[1
]}

TOYOTA, T ^{[1
]}

GOTO, Y ^{[1
]}

机构：

[1] TOHOKU UNIV,SCH MED,INST EXPTL ANIM,SENDAI,MIYAGI 980,JAPAN

来源：

DIABETES | 1988年 / 37卷 / 09期

关键词：

D O I：

10.2337/diabetes.37.9.1188

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1188 / 1194

页数：7

共 42 条

[1] INVIVO PREVENTION OF THYROID AND PANCREATIC AUTOIMMUNITY IN THE BB RAT BY ANTIBODY TO CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX GENE-PRODUCTS [J].

BOITARD, C ;

MICHIE, S ;

SERRURIER, P ;

BUTCHER, GW ;

LARKINS, AP ;

MCDEVITT, HO .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) :6627-6631

[2] CONTINUOUS, CLONAL, INSULIN-SECRETING AND SOMATOSTATIN-SECRETING CELL-LINES ESTABLISHED FROM A TRANSPLANTABLE RAT ISLET CELL TUMOR [J].

GAZDAR, AF ;

CHICK, WL ;

OIE, HK ;

SIMS, HL ;

KING, DL ;

WEIR, GC ;

LAURIS, V .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3519-3523

[3] INCREASE IN REMISSION RATE IN NEWLY DIAGNOSED TYPE-1 DIABETIC SUBJECTS TREATED WITH AZATHIOPRINE [J].

HARRISON, LC ;

COLMAN, PG ;

DEAN, B ;

BAXTER, R ;

MARTIN, FIR .

DIABETES, 1985, 34 (12) :1306-1308

[4] QUANTITATIVE-DETERMINATION OF ISLET CELL-SURFACE ANTIBODIES USING I-125-PROTEIN-A [J].

HUEN, AHJ ;

HANEDA, M ;

FREEDMAN, Z ;

LERNMARK, A ;

RUBENSTEIN, AH .

DIABETES, 1983, 32 (05) :460-465

[5]

ICHIMURA O, 1985, INT J IMMUNOPHARMACO, V7, P263

[6] PREVENTION OF TYPE-I DIABETES IN NONOBESE DIABETIC MICE BY ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

IKEHARA, S ;

OHTSUKI, H ;

GOOD, RA ;

ASAMOTO, H ;

NAKAMURA, T ;

SEKITA, K ;

MUSO, E ;

TOCHINO, Y ;

IDA, T ;

KUZUYA, H ;

IMURA, H ;

HAMASHIMA, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (22) :7743-7747

[7] IMMUNOLOGICAL ASPECTS OF THE NON-OBESE DIABETIC (NOD) MOUSE - ABNORMALITIES OF CELLULAR-IMMUNITY [J].

KATAOKA, S ;

SATOH, J ;

FUJIYA, H ;

TOYOTA, T ;

SUZUKI, R ;

ITOH, K ;

KUMAGAI, K .

DIABETES, 1983, 32 (03) :247-253

[8] ACTIVATION OF MACROPHAGE FUNCTION BY INTRAPERITONEAL ADMINISTRATION OF THE STREPTOCOCCAL ANTI-TUMOR AGENT OK-432 [J].

KAWAGUCHI, T ;

SUEMATSU, M ;

KOIZUMI, HM ;

MITSUI, H ;

SUZUKI, S ;

MATSUNO, T ;

OGAWA, H ;

NOMOTO, K .

IMMUNOPHARMACOLOGY, 1983, 6 (03) :177-189

[9] PREVENTIVE EFFECT OF MONOCLONAL ANTI-L3T4 ANTIBODY ON DEVELOPMENT OF DIABETES IN NOD MICE [J].

KOIKE, T ;

ITOH, Y ;

ISHII, T ;

ITO, I ;

TAKABAYASHI, K ;

MARUYAMA, N ;

TOMIOKA, H ;

YOSHIDA, S .

DIABETES, 1987, 36 (04) :539-541

[10]

LAUPACIS A, 1983, LANCET, V1, P10

← 1 2 3 4 5 →